1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6BE4629E1531FF08A85256DBB00623AAA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/in-licensing-process-steps-to-accelerate-assessment-and-agreement?opendocument
18
19
20
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services New Product Development New Product Planning

In-Licensing Process: Steps to Accelerate Assessment and Agreement

DB Image

ID: 4499


Features:

Metrics, Graphics


Words: 6,799


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This 22-page document examines key processes that drive high-performing in-licensing operations. Nineteen best practices and more than a dozen narratives from business development executives at leading pharmaceutical companies detail the most effective ways to create quality, efficiency and clarity in evaluation, agreement and communication in in-licensing organizations. This document originated in a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Medical Device; Biotech; Health Care; Chemical


Companies Profiled:
AstraZeneca; Sanofi-aventis; Roche; Johnson & Johnson; Novartis; GlaxoSmithKline; Genentech; Bristol-Myers Squibb


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.